<DOC>
	<DOCNO>NCT00684814</DOCNO>
	<brief_summary>The purpose study compare bioequivalence test formulation zolpidem tartrate tablet equivalent oral dose commercially available reference drug product Ambien速 ( zolpidem tartrate tablet ) adult subject fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Zolpidem Tartrate Tablets Ambien速 Under Fasting Conditions</brief_title>
	<detailed_description>The purpose study compare bioequivalence test formulation zolpidem tartrate tablet equivalent oral dose commercially available reference drug product Ambien速 ( zolpidem tartrate tablet ) adult subject fast condition . Thirty-eight healthy , non-smoking , non-obese male female volunteer least 18 year age randomly assign crossover fashion receive two zolpidem tartrate dose regimen sequence 7 day washout period dose period . On morning Day 1 , overnight fast least 10 hour , subject receive either single oral dose test formulation , zolpidem tartrate ( 1 x 10 mg tablet ) single oral dose reference formulation , Ambien速 ( 1 x 10 mg tablet ) . After 7 day washout period , morning Day 8 overnight fast , subject receive alternate regimen . Blood sample draw participant dose 12 hour post dose time sufficient adequately define pharmacokinetics zolpidem tartrate . A goal study evaluate safety tolerability regimen healthy volunteer . Subjects monitor throughout confinement portion study adverse reaction study drug and/or procedure . Blood pressure pulse rate obtain prior dose 0.5 , 1 , 2 , 4 12 hour post-dose . All adverse event whether elicited query , spontaneously report observed clinic staff evaluate investigator report subject 's case report form .</detailed_description>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Sex : Male Female ; similar proportion preferred Age : At least 18 year Weight : must 15 % ideal weight height frame Subjects must good health physical condition determine medical history Subjects must read sign Consent Form History treatment alcoholism , substance abuse , drug abuse within past 24 month . History malignancy , stroke , diabetes , cardiac , renal liver disease , serious illness . History GERD , malabsorption syndrome , colon cancer , chronic colitis , include Crohn 's disease . History treatment asthma within past five ( 5 ) year . History mental depression . History pulmonary disease . History sleep apnea . Females pregnant lactating . History hypersensitivity zolpidem tartrate , hypnotic sedative . Treatment investigational drug four week prior initial dose study . Donation blood within four week prior initial dose study Smokers subject use tobacco/nicotine product . Three month abstinence require .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>equivalency</keyword>
	<keyword>Therapeutic equivalency</keyword>
</DOC>